115 studies found for:    "Sham injection"
Show Display Options
Rank Status Study
1 Completed
Has Results
A Multicenter Study to Compare Multiple Doses of Intravitreal Microplasmin Versus Sham Injection for Treatment of Patients With Diabetic Macular Edema (DME)
Condition: Diabetic Macular Edema
Interventions: Drug: ocriplasmin;   Other: Sham injection
2 Completed
Has Results
A Phase 3 Study To Compare The Efficacy And Safety Of 0.3 MG Pegaptanib Sodium To Sham Injections In Subjects With Diabetic Macular Edema
Conditions: Macular Edema;   Diabetic Mellitus;   Retinal Disease
Interventions: Drug: pegaptanib sodium;   Other: sham injection
3 Completed
Has Results
Safety and Efficacy Study of Intravitreal Ocriplasmin in Subjects With AMD With Focal Vitreomacular Adhesion
Conditions: Exudative Age-Related Macular Degeneration;   Focal Vitreomacular Adhesion
Interventions: Drug: Ocriplasmin;   Drug: Sham injection
4 Completed
Has Results
A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRAVO)
Conditions: Macular Edema;   Retinal Vein Occlusion
Interventions: Drug: Ranibizumab injection 0.3 mg;   Drug: Ranibizumab injection 0.5 mg;   Drug: Sham injection
5 Completed
Has Results
A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion (CRUISE)
Conditions: Macular Edema;   Retinal Vein Occlusion
Interventions: Drug: Sham injection;   Drug: Ranibizumab injection 0.3 mg;   Drug: Ranibizumab injection 0.5 mg
6 Completed
Has Results
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Conditions: Proliferative Diabetic Retinopathy;   Diabetic Macular Edema
Interventions: Drug: Ranibizumab;   Drug: Triamcinolone Acetonide;   Behavioral: Sham injection;   Procedure: Focal/grid laser
7 Recruiting Japanese Phase 3 Study of Aflibercept in Neovascular Glaucoma Patients
Condition: Glaucoma, Neovascular
Interventions: Drug: Aflibercept (Eylea, BAY 86-5321);   Drug: Sham Injection
8 Active, not recruiting Fluocinolone Acetonide Intravitreal Inserts in Geographic Atrophy
Condition: Age-Related Macular Degeneration
Interventions: Drug: Fluocinolone Acetonide;   Drug: Sham Injection
9 Completed
Has Results
Prospective Randomized Controlled Study of Intravitreal Injection of Bevacizumab for Proliferative Diabetic Retinopathy
Conditions: Proliferative Diabetic Retinopathy;   Diabetic Traction Retinal Detachment;   Vitreous Hemorrhage
Interventions: Drug: Bevacizumab;   Procedure: Vitrectomy;   Device: Sham injection
10 Completed
Has Results
A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion
Conditions: Macular Edema;   Retinal Vein Occlusion
Interventions: Drug: 700 µg Dexamethasone;   Drug: 350 µg Dexamethasone;   Other: Sham Injection
11 Completed
Has Results
A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion
Conditions: Macular Edema;   Retinal Vein Occlusion
Interventions: Drug: 700 µg Dexamethasone;   Drug: 350 µg Dexamethasone;   Other: Sham Injection
12 Active, not recruiting Efficacy and Safety of Intravitreal Aflibercept Injection for Subacute Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Interventions: Drug: Intravitreal Aflibercept injection;   Drug: Sham injection;   Procedure: Half-fluence photodynamic therapy
13 Not yet recruiting A Study of the Safety and Tolerability of Intravitreal LKA651 in Patients With Diabetic Macular Edema
Condition: Diabetic Macular Edema
Interventions: Biological: LKA651 ophthalmic solution;   Biological: Ranibizumab ophthalmic solution;   Biological: Sham injection
14 Completed
Has Results
A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RIDE)
Conditions: Diabetes Mellitus;   Macular Edema
Interventions: Drug: Ranibizumab;   Drug: Sham injection
15 Completed
Has Results
A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE)
Conditions: Diabetes Mellitus;   Macular Edema
Interventions: Drug: Ranibizumab;   Drug: Sham injection
16 Completed Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole
Condition: Vitreomacular Adhesion Including Macular Hole
Interventions: Drug: Ocriplasmin;   Other: Sham injection
17 Completed Vitamin A and Very Low Birthweight Babies (VitAL)
Conditions: Preterm Birth;   Retinopathy of Prematurity
Interventions: Drug: Aquasol A;   Drug: aquasol A;   Other: sham injection
18 Active, not recruiting Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert
Conditions: Posterior Uveitis;   Intermediate Uveitis;   Panuveitis
Interventions: Drug: FAI insert;   Drug: Sham injection
19 Recruiting Optimization of Synvisc-One for Knee OA
Condition: Knee Osteoarthritis
Interventions: Device: Synvisc-One Injection;   Other: Sham Injection
20 Terminated Chronic Post Breast Surgery Pain
Condition: Breast Cancer
Interventions: Procedure: Paravertebral block;   Procedure: Sham injections

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years